Home Forums Melanoma Diagnosis: Stage IV Genentech PDL1 trial

  • This topic is empty.
Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
  • #20774

    Genentech recently updated their trial to increase enrollments & more locations including Europe. Increasing the enrollment & adding more locations could be an indication that this drug (MPDL3280A) is getting a good objective reaponse rate

    Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors


    Catherine Poole

    Thanks James, should be an interesting trial. I’ve not heard anything definitive about this therapy. Also, GSK has a PD1 moving slowly into the pipeline. These are good trials to get into as far as I can tell. Thanks for posting!

Viewing 2 posts - 1 through 2 (of 2 total)
  • The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.